Mainz Biomed B.V. (MYNZ )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol MYNZ
- Company Mainz Biomed B.V.
- Price $0.29
- Changes Percentage -10.31
- Change -0.033
- Day Low $0.24
- Day High $0.32
- Year High $3.39
- Year Low $0.19
- Market Cap $6,281,447
- Price Avg 50 EMA (D) $0.31
- Price Avg 200 EMA (D) $0.69
- Exchange NASDAQ
- Volume 3,729,505
- Average Volume 1,848,656
- Open $0.3
- Previous Close $0.32
- EPS -1.62
- PE -0.18
- Earnings Announcement 2024-11-11 13:30:00
- Shares Outstanding $21,886,576
Company brief: MAINZ BIOMED B.V. (MYNZ )
- Healthcare
- Medical - Diagnostics & Research
- Mr. Guido Baechler
- https://mainzbiomed.com
- DE
- N/A
- 11-05-2021
- NL0015000LC2
Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments on a molecular genetic basis; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.